DNA damage induced by alkylating agents and repair pathways

Journal of Nucleic Acids

Volumn 2010, Issue , 2010, Pages

  Kondo, Natsuko ^a   Takahashi, Akihisa ^b   Ono, Koji ^a   Ohnishi, Takeo ^b  

^a KYOTO UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 O METHYLGUANINE; ALKYLATING AGENT; CELL DNA; CHLORAMBUCIL; CHLORMETHINE; CHLOROETHYLNITROSOUREA; CYCLOPHOSPHAMIDE; DNA METHYLTRANSFERASE; DOUBLE STRANDED DNA; IFOSFAMIDE; MELPHALAN; NITROGEN; OXYGEN; PROTEIN KINASE; RAD50 PROTEIN; RAD51 PROTEIN; RAD54 PROTEIN;

CYTOTOXICITY; DNA ADDUCT; DNA CROSS LINKING; DNA DAMAGE; DNA REPAIR; DOUBLE STRANDED DNA BREAK; DRUG INDUCED DISEASE; DRUG MECHANISM; EXCISION REPAIR; FANCONI ANEMIA; HOMOLOGOUS RECOMBINATION; HUMAN; MISMATCH REPAIR; MUTAGENICITY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; XERODERMA PIGMENTOSUM;

RODENTIA;

EID: 84857126520     PISSN: 20900201     EISSN: 2090021X     Source Type: Journal    
DOI: 10.4061/2010/543531     Document Type: Review

References (66)

1. Chaney S. G., Sancar A., DNA repair: enzymatic mechanisms and relevance to drug response. Journal of the National Cancer Institute 1996 88 19 1346 1360 2-s2.0-0029762815 (Pubitemid 26329752)
2. Beranek D. T., Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutation Research 1990 231 1 11 30 2-s2.0-0025288239 (Pubitemid 20195889)
3. Goth R., Rajewsky M. F., Persistence of O6 ethylguanine in rat brain DNA: correlation with nervous system specific carcinogenesis by ethylnitrosourea. Proceedings of the National Academy of Sciences of the United States of America 1974 71 3 639 643 2-s2.0-0016042235
4. Goth-Goldstein R., Inability of Chinese hamster ovary cells to excise O6 -alkylguanine. Cancer Research 1980 40 7 2623 2624 2-s2.0-0019034993
5. Kaina B., van Zeeland A. A., de Groot A., Natarajan A. T., DNA repair and chromosomal stability in the alkylating agent-hypersensitive Chinese hamster cell line 27-1. Mutation Research 1990 243 3 219 224 2-s2.0-0025141393 (Pubitemid 20062083)
6. Margison G. P., Santibáñez-Koref M. F., Povey A. C., Mechanisms of carcinogenicity/chemotherapy by O6 -methylguanine. Mutagenesis 2002 17 6 483 487 2-s2.0-0036856459
7. Christmann M., Tomicic M. T., Roos W. P., Kaina B., Mechanisms of human DNA repair: an update. Toxicology 2003 193 1-2 3 34 2-s2.0-0242331221 10.1016/S0300-483X(03)00287-7 (Pubitemid 37340141)
8. Wyatt M. D., Allan J. M., Lau A. Y., Ellenberger T. E., Samson L. D., 3-Methyladenine DNA glycosylases: structure, function, and biological importance. BioEssays 1999 21 8 668 676 2-s2.0-0033180391 (Pubitemid 29384448)
9. Krokan H. E., Standal R., Slupphaug G., DNA glycosylases in the base excision repair of DNA. Biochemical Journal 1997 325 1 1 16 2-s2.0-0030861915 (Pubitemid 27322679)
10. Kaina B., Christmann M., Naumann S., Roos W. P., MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair 2007 6 8 1079 1099 2-s2.0-34447314728 10.1016/j.dnarep.2007. 03.008 (Pubitemid 47058389)
11. Sancar A., Excision repair in mammalian cells. The Journal of Biological Chemistry 1995 270 27 15915 15918 2-s2.0-0029001182
12. Chen H. T., Bhandoola A., Difilippantonio M. J., Zhu J., Brown M. J., Tai X., Rogakou E. P., Brotz T. M., Bonner W. M., Ried T., Nussenzweig A., Response to RAG-mediated V(D)J cleavage by NBS1 and γ -H2AX. Science 2000 290 5498 1962 1964 2-s2.0-0034623860 10.1126/science.290.5498.1962
13. 6 -alkylguanine-DNA alkyltransferase: role in carcinogenesis and chemotherapy. BioEssays 2002 24 3 255 266 2-s2.0-0036006173 10.1002/bies.10063 (Pubitemid 34248691)
14. Roos W. P., Nikolova T., Quiros S., Naumann S. C., Kiedron O., Zdzienicka M. Z., Kaina B., Brca2/Xrcc2 dependent HR, but not NHEJ, is required for protection against O6 -methylguanine triggered apoptosis, DSBs and chromosomal aberrations by a process leading to SCEs. DNA Repair 2009 8 1 72 86 2-s2.0-56549122306 10.1016/j.dnarep.2008.09.003
15. Kondo N., Takahashi A., Mori E., Ohnishi K., McKinnon P. J., Sakaki T., Nakase H., Ohnishi T., DNA ligase IV as a new molecular target for temozolomide. Biochemical and Biophysical Research Communications 2009 387 4 656 660 2-s2.0-68549134901 10.1016/j.bbrc.2009.07.045
16. Drablos F., Feyzi E., Aas P. A., Vaagbo C. B., Kavli B., Bratlie M. S., Peña-Diaz J., Otterlei M., Slupphaug G., Krokan H. E., Alkylation damage in DNA and RNA - repair mechanisms and medical significance. DNA Repair 2004 3 11 1389 1407 2-s2.0-4544339891 10.1016/j.dnarep.2004.05.004 (Pubitemid 39221738)
17. Day R. S. III, Ziolkowski C. H. J., Scudiero D. A., Defective repair of alkylated DNA by human tumour and SV40-transformed human cell strains. Nature 1980 288 5792 724 727 2-s2.0-0019202685 (Pubitemid 11168534)
18. Hosoya N., nhosoya-tky@umin.ac.jp Miyagawa K., miyag-tky@umin.ac.jp Clinical importance of DNA repair inhibitors in cancer therapy. Memo - Magazine of European Medical Oncology 2009 2 1 9 14 10.1007/s12254-008-0081-7
19. 6 -methylguanine-DNA methyltransferase regulation by p53 in astrocytic cells. Cancer Research 2007 67 2 580 584 2-s2.0-33846695481 10.1158/0008-5472.CAN-06- 2782 (Pubitemid 46192195)
20. Russell S. J., Ye Y.-W., Waber P. G., Shuford M., Schold S. C. Jr., Nisen P. D., p53 Mutations, O6 -alkylguanine DNA alkyltransferase activity, and sensitivity to procarbazine in human brain tumors. Cancer 1995 75 6 1339 1342 2-s2.0-0028985860
21. Esteller M., Hamilton S. R., Burger P. C., Baylin S. B., Herman J. G., Inactivation of the DNA repair gene O6 -methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Research 1999 59 4 793 797 2-s2.0-0033557903 (Pubitemid 29086728)
22. 6 -methylguanine-DNA methyltransferase activity in breast and brain tumors. International Journal of Cancer 1995 61 3 321 326 2-s2.0-0028988143
23. Lees N. P., Harrison K. L., Hill E., Nicholas Hall C., Povey A. C., Margison G. P., Heterogeneity of O6 -alkylguanine-DNA alkyltransferase activity in colorectal cancer: implications for treatment. Oncology 2002 63 4 393 397 2-s2.0-0036968081 10.1159/000066221 (Pubitemid 36151533)
24. Karran P., Mechanisms of tolerance to DNA damaging therapeutic drugs. Carcinogenesis 2001 22 12 1931 1937 2-s2.0-0035687887 (Pubitemid 34065386)
25. Stojic L., Brun R., Jiricny J., Mismatch repair and DNA damage signalling. DNA Repair 2004 3 8-9 1091 1101 2-s2.0-3242885728 10.1016/j.dnarep.2004.06.006 (Pubitemid 38997952)
26. Branch P., Aquilina G., Bignami M., Karran P., Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature 1993 362 6421 652 654 2-s2.0-0027502938 10.1038/362652a0 (Pubitemid 23109278)
27. Kat A., Thilly W. G., Fang W.-H., Longley M. J., Li G.-M., Modrich P., An alkylation-tolerant, mutator human cell line is deficient in strand- specific mismatch repair. Proceedings of the National Academy of Sciences of the United States of America 1993 90 14 6424 6428 2-s2.0-0027292234 (Pubitemid 23207225)
28. Quiros S., Roos W. P., Kaina B., kaina@uni-mainz.de Processing of O6 -methylguanine into DNA double-strand breaks requires two rounds of replication whereas apoptosis is also induced in subsequent cell cycles. Cell Cycle 2010 9 1 168 178
29. Kondo N., Takahashi A., atakahas@naramed-u.ac.jp Mori E., Noda T., Su X., Ohnishi K., McKinnon P. J., Sakaki T., Nakase H., Ono K., Ohnishi T., DNA ligase IV is a potential molecular target in ACNU sensitivity. Cancer Science 2010 101 8 1881 1885 10.1111/j.1349-7006.2010.01591.x
30. Naumann S. C., Roos W. P., Jöst E., Belohlavek C., Lennerz V., Schmidt C. W., Christmann M., Kaina B., Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53. British Journal of Cancer 2009 100 2 322 333 2-s2.0-58749097764 10.1038/sj.bjc.6604856
31. Ohnishi T., Mori E., Takahashi A., DNA double-strand breaks: their production, recognition, and repair in eukaryotes. Mutation Research 2009 669 1-2 8 12 2-s2.0-70349099568 10.1016/j.mrfmmm.2009.06.010
32. Davies A. A., Masson J. Y., McIlwraith M. J., Stasiak A. Z., Stasiak A., Venkitaraman A. R., West S. C., Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Molecular Cell 2001 7 2 273 282 2-s2.0-0035105999 10.1016/S1097-2765(01)00175-7 (Pubitemid 32206495)
33. Mojas N., Lopes M., Jiricny J., Mismatch repair-dependent processing of methylation damage gives rise to persistent single-stranded gaps in newly replicated DNA. Genes and Development 2007 21 24 3342 3355 2-s2.0-37249019677 10.1101/gad.455407 (Pubitemid 350277760)
34. Helleday T., Lo J., van Gent D. C., Engelward B. P., DNA double-strand break repair: from mechanistic understanding to cancer treatment. DNA Repair 2007 6 7 923 935 2-s2.0-34249945536 10.1016/j.dnarep.2007.02.006 (Pubitemid 46880473)
35. Sobol R. W., Wilson S. H., Mammalian DNA β -polymerase in base excision repair of alkylation damage. Progress in Nucleic Acid Research and Molecular Biology 2001 68 57 74 2-s2.0-0035225929 (Pubitemid 33804653)
36. Wilson S. H., Sobol R. W., Beard W. A., Horton J. K., Prasad R., Vande Berg B. J., DNA polymerase β and mammalian base excision repair. Cold Spring Harbor Symposia on Quantitative Biology 2000 65 143 155 2-s2.0-0034437673 (Pubitemid 32611936)
37. Sobol R. W., Horton J. K., Kühn R., Gu H., Singhal R. K., Prasad R., Rajewsky K., Wilson S. H., Requirement of mammalian DNA polymerase- β in base-excision repair. Nature 1996 379 6561 183 186 2-s2.0-0030030379 10.1038/379183a0 (Pubitemid 26020204)
38. Sobol R. W., Prasad R., Evenski A., Baker A., Yang X.-P., Horton J. K., Wilson S. H., The lyase activity of the DNA repair protein β -polymerase protects from DNA-damage-induced cytotoxicity. Nature 2000 405 6788 807 810 2-s2.0-0034659935 10.1038/35015598 (Pubitemid 30407855)
39. Prasad R., Bebenek K., Hou E., Shock D. D., Beard W. A., Woodgate R., Kunkel T. A., Wilson S. H., Localization of the deoxyribose phosphate lyase active site in human DNA polymerase β by controlled proteolysis. The Journal of Biological Chemistry 2003 278 32 29649 29654 2-s2.0-0042031052 10.1074/jbc.M305399200 (Pubitemid 36962349)
40. Bebenek K., Tissier A., Frank E. G., McDonald J. P., Prasad R., Wilson S. H., Woodgate R., Kunkel T. A., 5′ -deoxyribose phosphate lyase activity of human DNA polymerase L in vitro. Science 2001 291 5511 2156 2159 2-s2.0-0035896008 10.1126/science.1058386 (Pubitemid 32224447)
41. García-Díaz M., Bebenek K., Kunkel T. A., Blanco L., Identification of an intrinsic 5′ -deoxyribose-5-phosphate lyase activity in human DNA polymerase λ: a possible role in base excision repair. The Journal of Biological Chemistry 2001 276 37 34659 34663 2-s2.0-0035860767 10.1074/jbc.M106336200
42. Lindahl T., Wood R. D., Quality control by DNA repair. Science 1999 286 5446 1897 1905 2-s2.0-0033520969 10.1126/science.286.5446.1897 (Pubitemid 129515891)
43. Sobolt R. W., Kartalou M., Almeida K. H., Joyce D. F., Engelward B. P., Horton J. K., Prasad R., Samson L. D., Wilson S. H., Base excision repair intermediates induce p53-independent cytotoxic and genotoxic responses. The Journal of Biological Chemistry 2003 278 41 39951 39959 2-s2.0-0141925645 10.1074/jbc.M306592200 (Pubitemid 37248559)
44. Sobol R. W., Watson D. E., Nakamura J., Yakes F. M., Hou E., Horton J. K., Ladapo J., Van Houten B., Swenberg J. A., Tindall K. R., Samson L. D., Wilson S. H., Mutations associated with base excision repair deficiency and methylation-induced genotoxic stress. Proceedings of the National Academy of Sciences of the United States of America 2002 99 10 6860 6865 2-s2.0-0037076434 10.1073/pnas.092662499 (Pubitemid 34526223)
45. Horton J. K., Joyce-Gray D. F., Pachkowski B. F., Swenberg J. A., Wilson S. H., Hypersensitivity of DNA polymerase β null mouse fibroblasts reflects accumulation of cytotoxic repair intermediates from site-specific alkyl DNA lesions. DNA Repair 2003 2 1 27 48 2-s2.0-0037413370 10.1016/S1568-7864(02) 00184-2 (Pubitemid 35435437)
46. Trivedi R. N., Almeida K. H., Fornsaglio J. L., Schamus S., Sobol R. W., The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell death. Cancer Research 2005 65 14 6394 6400 2-s2.0-22244448679 10.1158/0008-5472.CAN-05-0715 (Pubitemid 40994427)
47. Rogakou E. P., Pilch D. R., Orr A. H., Ivanova V. S., Bonner W. M., DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. The Journal of Biological Chemistry 1998 273 10 5858 5868 2-s2.0-0032489520 10.1074/jbc.273.10.5858 (Pubitemid 28124064)
48. Ward I. M., Chen J., Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. The Journal of Biological Chemistry 2001 276 51 47759 47762 2-s2.0-0035930537
49. Curtin N. J., Wang L.-Z., Yiakouvaki A., Kyle S., Arris C. A., Canan-Koch S., Webber S. E., Durkacz B. W., Calvert H. A., Hostomsky Z., Newell D. R., Novel poly(ADP-ribose) polymerase-1 inhibitor, AG14361, restores rensitivity to temozolomide in mismatch repair-deficient cells. Clinical Cancer Research 2004 10 3 881 889 2-s2.0-10744233628 10.1158/1078-0432.CCR-1144-3 (Pubitemid 38198886)
50. Duncan T., Trewick S. C., Koivisto P., Bates P. A., Lindahl T., Sedgwick B., Reversal of DNA alkylation damage by two human dioxygenases. Proceedings of the National Academy of Sciences of the United States of America 2002 99 26 16660 16665 2-s2.0-0037168654 10.1073/pnas.262589799 (Pubitemid 36034029)
51. Aas P. A., Otterlei M., Falnes P. O., Vågbo C. B., Skorpen F., Akbari M., Sundheim O., Bjorås M., Slupphaug G., Seeberg E., Krokan H. E., Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA. Nature 2003 421 6925 859 863 2-s2.0-0037456369 10.1038/nature01363 (Pubitemid 36258356)
52. O'Connor P. M., Kohn K. W., Comparative pharmacokinetics of DNA lesion formation and removal following treatment of L1210 cells with nitrogen mustards. Cancer Communications 1990 2 12 387 394 2-s2.0-0025676339
53. Middleton M. R., Margison G. P., Improvement of chemotherapy efficacy by inactivation of a DNA-repair pathway. Lancet Oncology 2003 4 1 37 44 2-s2.0-0037243405 10.1016/S1470-2045(03)00959-8 (Pubitemid 36124189)
54. Thompson L. H., Hinz J. M., Cellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: mechanistic insights. Mutation Research 2009 668 1-2 54 72 2-s2.0-67349107395 10.1016/j.mrfmmm.2009.02.003
55. Yamamoto K., Ishiai M., Matsushita N., Arakawa H., Lamerdin J. E., Buerstedde J.-M., Tanimoto M., Harada M., Thompson L. H., Takata M., Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells. Molecular and Cellular Biology 2003 23 15 5421 5430 2-s2.0-0043092640 10.1128/MCB.23.15. 5421-5430.2003 (Pubitemid 36950896)
56. Nakanishi K., Yang Y.-G., Pierce A. J., Taniguchi T., Digweed M., D'Andréa A. D., Wang Z.-Q., Jasin M., Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proceedings of the National Academy of Sciences of the United States of America 2005 102 4 1110 1115 2-s2.0-12844286052 10.1073/pnas.0407796102 (Pubitemid 40170734)
57. Meetei A. R., Medhurst A. L., Ling C., Xue Y., Singh T. R., Bier P., Steltenpool J., Stone S., Dokal I., Mathew C. G., Hoatlin M., Joenje H., De Winter J. P., Wang W., A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nature Genetics 2005 37 9 958 963 2-s2.0-25144449181 10.1038/ng1626 (Pubitemid 43086152)
58. Ciccia A., Ling C., Coulthard R., Yan Z., Xue Y., Meetei A. R., Laghmani E. H., Joenje H., McDonald N., de Winter J. P., Wang W., West S. C., Identification of FAAP24, a Fanconi Anemia Core Complex Protein that Interacts with FANCM. Molecular Cell 2007 25 3 331 343 2-s2.0-33846799430 10.1016/j.molcel.2007.01.003 (Pubitemid 46206138)
59. Masuda Y., Ohmae M., Masuda K., Kamiya K., Structure and enzymatic properties of a stable complex of the human REV1 and REV7 proteins. The Journal of Biological Chemistry 2003 278 14 12356 12360 2-s2.0-0038823615 10.1074/jbc.M211765200 (Pubitemid 36800219)
60. Dronkert M. L. G., Kanaar R., Repair of DNA interstrand cross-links. Mutation Research 2001 486 4 217 247 2-s2.0-0035807079 10.1016/S0921-8777(01) 00092-1 (Pubitemid 32763210)
61. Hegi M. E., Diserens A.-C., Gorlia T., Hamou M.-F., De Tribolet N., Weller M., Kros J. M., Hainfellner J. A., Mason W., Mariani L., Bromberg J. E. C., Hau P., Mirimanoff R. O., Cairncross J. G., Janzer R. C., Stupp R., MGMT gene silencing and benefit from temozolomide in glioblastoma. The New England Journal of Medicine 2005 352 10 997 1003 2-s2.0-20044372154 10.1056/NEJMoa043331 (Pubitemid 40349502)
62. Esteller M., Garcia-Foncillas J., Andion E., Goodman S. N., Hidalgo O. F., Vanaclocha V., Baylin S. B., Herman J. G., Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. The New England Journal of Medicine 2000 343 13 1350 1354 2-s2.0-0034626988 10.1056/NEJM200011093431901
63. Helleday T., Petermann E., Lundin C., Hodgson B., Sharma R. A., DNA repair pathways as targets for cancer therapy. Nature Reviews Cancer 2008 8 3 193 204 2-s2.0-39749166975 10.1038/nrc2342 (Pubitemid 351301852)
64. Quinn J. A., Desjardins A., Weingart J., Brem H., Dolan M. E., Delaney S. M., Vredenburgh J., Rich J., Friedman A. H., Reardon D. A., Sampson J. H., Pegg A. E., Moschel R. C., Birch R., McLendon R. E., Provenzale J. M., Gururangan S., Dancey J. E., Maxwell J., Tourt-Uhlig S., Herndon J. E. II, Bigner D. D., Friedman H. S., Phase I trial of temozolomide plus O6 -benzylguanine for patients with recurrent or progressive malignant glioma. Journal of Clinical Oncology 2005 23 28 7178 7187 2-s2.0-27244442921 10.1200/JCO.2005.06.502
65. Khan O., Middleton M. R., The therapeutic potential of O6 -alkylguanine DNA alkyltransferase inhibitors. Expert Opinion on Investigational Drugs 2007 16 10 1573 1584 2-s2.0-35248889546 10.1517/13543784.16.10.1573 (Pubitemid 350041358)
66. Giese A., Kucinski T., Knopp U., Goldbrunner R., Hamel W., Mehdorn H. M., Tonn J. C., Hilt D., Westphal M., Pattern of recurrence following local chemotherapy with biodegradable carmustine (BCNU) implants in patients with glioblastoma. Journal of Neuro-Oncology 2004 66 3 351 360 2-s2.0-1342308418 10.1023/B:NEON.0000014539.90077.db (Pubitemid 38258351)